Thursday, April 27, 2017

BRIEF-Regeneron and Sanofi announce Kevzara license application resubmission for review by FDA

* Regeneron and Sanofi announce Kevzara® (sarilumab)

Biologics License Application resubmission accepted for review

by U.S. FDA

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)